Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,780	3,964	2,454	1,861	301	716
Market Cap Growth	37.33%	61.50%	31.89%	517.27%	-57.88%	6.05%
Enterprise Value	6,183	6,397	4,753	4,505	2,977	3,313
Last Close Price	11.85	12.60	7.92	6.07	1.99	4.79
PE Ratio	53.86	57.27	-20.84	-12.65	-2.31	68.43
Forward PE	11.96	15.04	11.69	11.92	2.71	5.65
PEG Ratio	-	0.51	0.51	0.51	0.18	0.66
PS Ratio	1.25	1.31	0.88	0.78	0.14	0.34
PB Ratio	633.93	-27.89	-11.22	46.76	0.62	0.98
P/TBV Ratio	-27.08	-28.80	-11.18	26.87	-	-
P/FCF Ratio	15.68	16.44	10.45	6.23	18.49	3.75
P/OCF Ratio	11.12	11.66	8.32	5.38	4.63	2.96
EV/Sales Ratio	2.05	2.12	1.70	1.88	1.35	1.58
EV/EBITDA Ratio	9.60	10.36	9.79	10.39	20.50	8.58
EV/EBIT Ratio	14.70	16.23	19.07	22.04	-31.36	21.69
EV/FCF Ratio	25.64	26.53	20.25	15.08	182.60	17.35
Debt / Equity Ratio	-40.81	-40.81	-15.27	33.23	7.13	3.77
Debt / EBITDA Ratio	4.35	4.35	5.34	6.34	19.59	7.45
Debt / FCF Ratio	11.15	11.15	11.05	9.21	174.50	15.07
Net Debt / Equity Ratio	-16.73	-16.73	-11.31	66.63	5.83	3.60
Net Debt / EBITDA Ratio	3.85	3.85	5.10	6.11	19.35	6.78
Net Debt / FCF Ratio	9.86	9.86	10.54	8.87	172.33	13.72
Asset Turnover	0.84	0.84	0.80	0.66	0.57	0.53
Inventory Turnover	3.13	3.13	2.97	2.83	2.80	2.70
Quick Ratio	1.37	1.37	0.79	0.84	1.03	1.36
Current Ratio	2.17	2.17	1.41	1.63	1.88	2.24
Return on Equity (ROE)	-116.61%	-116.61%	203.14%	-20.55%	-44.55%	2.78%
Return on Assets (ROA)	10.09%	10.09%	9.60%	6.80%	-2.52%	2.47%
Return on Invested Capital (ROIC)	13.79%	13.79%	12.21%	8.15%	-3.05%	3.17%
Return on Capital Employed (ROCE)	15.25%	15.25%	9.98%	7.21%	-3.01%	4.63%
Earnings Yield	1.91%	1.75%	-4.80%	-7.91%	-43.22%	1.46%
FCF Yield	6.38%	6.08%	9.57%	16.06%	5.41%	26.67%
Buyback Yield / Dilution	-5.12%	-5.12%	-75.42%	-	-	-
Total Shareholder Return	-5.12%	-5.12%	-75.42%	-	-	-

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q